SKI Market

Indian Indices

Sensex

82,307.37 397.74
( 0.49%)

Global Indices

Nasdaq

49,100.54 590.94
(1.22%)

Dow Jones

6,896.35 78.48
(1.15%)

Hang Seng

53,761.00 986.36
(1.87%)

Nikkei 225

10,161.37 23.28
(0.23%)

Forex

USD-INR

91.00 0.14
(0.15%)

EUR-INR

106.48 0.79
(0.75%)

GBP-INR

122.37 0.53
(0.44%)

JPY-INR

0.58 0.00
(0.11%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

swadha nature ltd

Bafna Pharmaceuticals standalone net profit rises 19.08% in the September 2025 quarter

Nov 12,2025

Net profit of Bafna Pharmaceuticals rose 19.08% to Rs 3.12 crore in the quarter ended September 2025 as against Rs 2.62 crore during the previous quarter ended September 2024. Sales declined 12.03% to Rs 35.47 crore in the quarter ended September 2025 as against Rs 40.32 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	35.47	40.32	-12
OPM %	12.04	9.42	-
PBDT	4.59	4.20	9
PBT	3.12	2.62	19
NP	3.12	2.62	19

82,307.37 397.74 ( 0.49%)

49,100.54 590.94 (1.22%)

6,896.35 78.48 (1.15%)

53,761.00 986.36 (1.87%)

10,161.37 23.28 (0.23%)

91.00 0.14 (0.15%)

106.48 0.79 (0.75%)

122.37 0.53 (0.44%)

0.58 0.00 (0.11%)